Anti-protein aggregation is a potential target for preventing delayed neuronal death after transient ischemia

Albers, 2002, Transient ischemic attack – proposal for a new definition, N Engl J Med, 347, 1713, 10.1056/NEJMsb020987 Kirino, 1982, Delayed neuronal death in the gerbil hippocampus following ischemia, Brain Res, 239, 57, 10.1016/0006-8993(82)90833-2 Hu, 2000, Protein aggregation after transient cerebral ischemia, J Neurosci, 20, 3191, 10.1523/JNEUROSCI.20-09-03191.2000 Hu, 2001, Protein aggregation after focal brain ischemia and reperfusion, J Cereb Blood Flow Metab, 21, 865, 10.1097/00004647-200107000-00012 Giffard, 2004, Chaperones, protein aggregation, and brain protection from hypoxic/ischemic injury, J Exp Biol, 207, 3213, 10.1242/jeb.01034 Ge, 2007, Protein aggregation and proteasome dysfunction after brain ischemia, Stroke, 38, 3230, 10.1161/STROKEAHA.107.487108 McNaught, 2006, Protein aggregation in the pathogenesis of familial and sporadic Parkinson’s disease, Neurobiol Aging, 27, 530, 10.1016/j.neurobiolaging.2005.08.012 Reixach, 2004, Tissue damage in the amyloidoses: transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture, Proc Natl Acad Sci USA, 101, 2817, 10.1073/pnas.0400062101 Gales, 2005, Towards a structural understanding of the fibrilization pathway in Machado-Joseph’s disease: trapping early oligomers of non-expanded ataxin-3, J Mol Biol, 353, 642, 10.1016/j.jmb.2005.08.061 Burdick, 1992, Assembly and aggregation properties of synthetic Alzheimer’s A4/beta amyloid peptide analogs, J Biol Chem, 267, 546, 10.1016/S0021-9258(18)48529-8 Kim, 2006, Role of polyunsaturated fatty acids for misfolding protein aggregations: implication for neurodegenerative diseases, Ann N Y Acad Sci, 1086, 11, 10.1196/annals.1377.021 Gregersen, 2005, Protein misfolding, aggregation, and degradation in disease, Mol Biotechnol, 31, 141, 10.1385/MB:31:2:141 Stefani, 2003, Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution, J Mol Med, 81, 678, 10.1007/s00109-003-0464-5 Kopito, 2000, Aggresomes, inclusion bodies and protein aggregation, Trends Cell Biol, 10, 524, 10.1016/S0962-8924(00)01852-3 Hu, 2001, Protein aggregation after focal brain ischemia and reperfusion, J Cereb Blood Flow Metab, 21, 865, 10.1097/00004647-200107000-00012 Nandi, 2006, The ubiquitin–proteasome system, J Biosci, 31, 137, 10.1007/BF02705243 Bukau, 2006, Molecular chaperones and protein quality control, Cell, 125, 443, 10.1016/j.cell.2006.04.014 Chaudhuri, 2006, Protein-misfolding diseases and chaperone-based therapeutic approaches, FEBS J, 273, 1331, 10.1111/j.1742-4658.2006.05181.x Liberek, 2008, Chaperones in control of protein disaggregation, EMBO J, 27, 328, 10.1038/sj.emboj.7601970 Griffiths, 2008, Emerging and potential therapies for Alzheimer’s disease, Expert Opin Ther Targets, 12, 693, 10.1517/14728222.12.6.693 Steffan, 2003, Targeting aggregation in the development of therapeutics for the treatment of Huntington’s disease and other polyglutamine repeat diseases, Expert Opin Ther Targets, 7, 201, 10.1517/14728222.7.2.201 de Almeida, 2007, Chemical chaperones reduce endoplasmic reticulum stress and prevent mutant HFE aggregate formation, J Biol Chem, 282, 27905, 10.1074/jbc.M702672200 Kubota, 2006, Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress, J Neurochem, 97, 1259, 10.1111/j.1471-4159.2006.03782.x Davies, 2006, Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy, Hum Mol Genet, 15, 23, 10.1093/hmg/ddi422 Arora, 2004, Inhibition of insulin amyloid formation by small stress molecules, FEBS Lett, 564, 121, 10.1016/S0014-5793(04)00326-6 Tanaka, 2004, Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease, Nat Med, 10, 148, 10.1038/nm985 Popiel, 2008, Delivery of the aggregate inhibitor peptide QBP1 into the mouse brain using PTDs and its therapeutic effect on polyglutamine disease mice, Neurosci Lett Shen, 2005, Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice, J Biol Chem, 280, 39962, 10.1074/jbc.M505524200 Ito, 2008, Effect of amino acids and amino acid derivatives on crystallization of hemoglobin and ribonuclease A, J Synchrotron Radiat, 15, 316, 10.1107/S0909049507068598